Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2111288 Target Snapshot

Cyclin-dependent kinase 7/ cyclin H · PROTEIN COMPLEX · Homo sapiens

612Compounds
132Assays
2Approved Drugs
429.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P51946. Use UniProt P51946 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P51946 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cyclin-dependent kinase 7/ cyclin H as ChEMBL target CHEMBL2111288, mapped to UniProt P51946. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cyclin-dependent kinase 7/ cyclin H
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2111288
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P51946
Cyclin-H
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cyclin-dependent kinase 7/ cyclin H is the right protein anchor across sources, using UniProt P51946 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCyclin-H
UniProt AccessionP51946
Component TypeProtein
Sequence Length323 aa

Cyclin-H

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cyclin-dependent kinase 7/ cyclin H, mapped to UniProt P51946. ChEMBL maps the protein component as Cyclin-H. Sequence length is 323 aa.

Mapped IDP51946
Review nameCyclin-dependent kinase 7/ cyclin H
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
9
Phase II
5
Phase I
Assay Mix

Activity Type Distribution

IC50289.0
KI125.0
KD15.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5088381 10.52 Kd 0.03 Preclinical
CHEMBL5080711 10.22 Kd 0.06 Preclinical
CHEMBL5090754 10.15 Kd 0.07 Preclinical
CHEMBL4791134 10.15 Kd 0.07 Preclinical
CHEMBL4786592 10.1 Kd 0.08 Preclinical
CHEMBL4782954 10.1 Kd 0.08 Preclinical
CHEMBL5083688 10.05 Kd 0.09 Preclinical
CHEMBL4790490 10.0 Kd 0.1 Preclinical
CHEMBL4779443 10.0 Kd 0.1 Preclinical
CHEMBL4786320 9.82 Kd 0.15 Preclinical
Distribution

pChEMBL Value Distribution

32
5.0
60
5.5
86
6.0
67
6.5
41
7.0
9
7.5
1
8.0
2
8.5
11
9.0
3
9.5
pChEMBL
Approved Drugs

Approved Drugs

QUIZARTINIB
CHEMBL576982
Approved 2023
Assay Landscape

Assay Landscape

132
Total Assays
290
Tested Compounds
1
Assay Types
Binding — 132 assays, 290 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 109 225 6.3
cell-based format 18 65 7.3
assay format 5 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine